• Schedule Iii Drugs Prescription Rules

According to Kentucky law (), Advanced Practice Registered Nurses (APRNs) have been authorized to prescribe non-scheduled legend drugs and controlled substances to their patients/clients after acquiring a written collaborative agreement with a physician licensed in Kentucky. Before an APRN engages in prescribing or dispensing non-scheduled legend drugs, the APRN must enter into a written collaborative agreement for prescriptive authority for non-scheduled drugs (CAPA-NS).

Controlled Substances. To 30-day supply of oral, transdermal or topical medication only). III-V (Medical Board may approve. Drug Classifications, Schedule I, II, III, IV, V The FDA has been overseeing drugs in the US since the beginning of the 20th century. In 1970 the FDA released the following drug classifications, or drug schedules, under the Controlled Substance Act (CSA).

Before the APRN is authorized to prescribe controlled substances to their patients/clients they must acquire a collaborative agreement (CAPA-CS) with a physician licensed in Kentucky in the same or similar practice. This collaborative agreement must meet the criteria established in. The administrative regulation establishes Advanced Practice Registered Nurse scope and standards of practice. The following document will be helpful in selecting a collaborating physician.

[PDF Format - 160KB] Limitations. Diazepam (Valium), clonazepam (Klonopin), lorazepam (Ativan), and alprazolam (Xanax): Prescriptions for these medications shall be limited to a thirty (30) day supply without any refills. Carisoprodol (Soma): Prescriptions for this medication shall be limited to a thirty (30) day supply without any refills. Combination hydrocodone products in liquid or solid dosage form: Prescriptions for these medications shall be limited to a thirty (30) day supply without any refills. Laws & Regulations on APRN Prescriptive Authority The document: [PDF Fomat - 19KB] may be helpful. Additional Information Call Nathan Goldman, General Counsel, at 502-429-3309.​​.

Schedule Iii Drugs Prescription Rules

Links with this icon indicate that you are leaving the CDC website. • The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. • Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.

• You will be subject to the destination website's privacy policy when you follow the link. • CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.

For more information on CDC's web notification policies, see.